{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:41:44Z","timestamp":1793400104115,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK128142"],"award-info":[{"award-number":["R01-DK128142"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's & Colitis Foundation","doi-asserted-by":"publisher","award":["R01DK132038"],"award-info":[{"award-number":["R01DK132038"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's & Colitis Foundation","doi-asserted-by":"publisher","award":["R01DK123233"],"award-info":[{"award-number":["R01DK123233"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's & Colitis Foundation","doi-asserted-by":"publisher","award":["623027"],"award-info":[{"award-number":["623027"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1053\/j.gastro.2025.04.028","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:36:31Z","timestamp":1747654591000},"page":"925-941.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition"],"prefix":"10.1053","volume":"169","author":[{"given":"Sophie","family":"Irwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"van Daelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Almaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becca","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Mahurkar-Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Q.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkeley","family":"Limketkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-0869","authenticated-orcid":false,"given":"Hon Wai","family":"Koon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.04.028_bib1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.04.028_bib2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1136\/gutjnl-2011-300777","article-title":"Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project","volume":"62","author":"Cleynen","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.04.028_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/gut.49.6.777","article-title":"Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease","volume":"49","author":"Louis","year":"2001","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.04.028_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.dld.2018.11.027","article-title":"Predictors of early recurrence after strictureplasty for Crohn's disease of the small bowel during the years of biologics","volume":"51","author":"Rottoli","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/2050640620947579","article-title":"Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease","volume":"8","author":"Rodriguez-Lago","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2025.04.028_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101251","article-title":"Recent advances in intestinal fibrosis","volume":"96","author":"Lenti","year":"2024","journal-title":"Mol Aspects Med"},{"key":"10.1053\/j.gastro.2025.04.028_bib7","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0140-6736(17)30317-3","article-title":"Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study","volume":"389","author":"Kugathasan","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.04.028_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/apt.14853","article-title":"An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease","volume":"48","author":"Rieder","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.04.028_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.crohns.2008.05.009","article-title":"Intestinal fibrosis in inflammatory bowel disease - current knowledge and future perspectives","volume":"2","author":"Rieder","year":"2008","journal-title":"J Crohns Colitis"},{"key":"10.1053\/j.gastro.2025.04.028_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12876-017-0619-4","article-title":"Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease","volume":"17","author":"Tran","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2025.04.028_bib11","article-title":"High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2025.04.028_bib12","article-title":"Imaging of strictures in Crohn's disease","volume":"13","author":"Minordi","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1053\/j.gastro.2025.04.028_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jcmgh.2022.06.011","article-title":"Elafin reverses intestinal fibrosis by inhibiting cathepsin S-mediated protease-activated receptor 2","volume":"14","author":"Xie","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.04.028_bib14","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.ajpath.2011.07.038","article-title":"Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells","volume":"179","author":"Koon","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2025.04.028_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/infdis\/jiae021","article-title":"Loratadine is an anti-inflammatory agent against C. difficile toxin B","volume":"230","author":"Xie","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12917-020-02451-y","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"16","author":"Percie du Sert","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1053\/j.gastro.2025.04.028_bib17","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/ibd.21638","article-title":"SAMP1\/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis","volume":"17","author":"Pizarro","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174121","article-title":"A novel model of colitis-associated cancer in SAMP1\/YitFc mice with Crohn's disease-like ileitis","volume":"12","author":"Menghini","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2025.04.028_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/OTT.S189391","article-title":"Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies","volume":"12","author":"Tan","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1053\/j.gastro.2025.04.028_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/2040620717721459","article-title":"Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis","volume":"8","author":"Gallogly","year":"2017","journal-title":"Ther Adv Hematol"},{"key":"10.1053\/j.gastro.2025.04.028_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-13-17","article-title":"Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRalpha: roles of Mcl-1 and beta-catenin","volume":"13","author":"Jin","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1053\/j.gastro.2025.04.028_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-021-01407-6","article-title":"Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRalpha: roles of Mcl-1 and beta-catenin","volume":"20","author":"Jin","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1053\/j.gastro.2025.04.028_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-319-91439-8_10","article-title":"Midostaurin: a multiple tyrosine kinases inhibitor in acute myeloid leukemia and systemic mastocytosis","volume":"212","author":"Schlenk","year":"2018","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/j.gastro.2025.04.028_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cid\/cir830","article-title":"Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection","volume":"54","author":"Venugopal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/joim.12690","article-title":"Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis","volume":"283","author":"Heldin","year":"2018","journal-title":"J Intern Med"},{"key":"10.1053\/j.gastro.2025.04.028_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114491","article-title":"New insights about the PDGF\/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies","volume":"161","author":"Pandey","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1053\/j.gastro.2025.04.028_bib27","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1073\/pnas.220413597","article-title":"Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A","volume":"97","author":"Fang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2025.04.028_bib28","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1046\/j.1432-1033.2003.03777.x","article-title":"Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase","volume":"270","author":"MacAulay","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1053\/j.gastro.2025.04.028_bib29","doi-asserted-by":"crossref","first-page":"L1348","DOI":"10.1152\/ajplung.00346.2007","article-title":"Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation","volume":"293","author":"Gosens","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1053\/j.gastro.2025.04.028_bib30","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2353\/ajpath.2010.100314","article-title":"Substance P modulates colitis-associated fibrosis","volume":"177","author":"Koon","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2025.04.028_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI12559","article-title":"The SAMP1\/Yit mouse: another step closer to modeling human inflammatory bowel disease","volume":"107","author":"Strober","year":"2001","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2025.04.028_bib32","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1093\/cid\/cis338","article-title":"Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI","volume":"55","author":"Louie","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib33","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/infdis\/jiad008","article-title":"Genistein inhibits Clostridioides difficile infection via estrogen receptors and lysine-deficient protein kinase 1","volume":"227","author":"Xie","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib34","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1093\/jac\/dky368","article-title":"Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb\/IV study (PROFILE)","volume":"73","author":"Hogenauer","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.gastro.2025.04.028_bib35","first-page":"278","article-title":"Fidaxomicin (Dificid), a novel oral macrocyclic antibacterial agent for the treatment of Clostridium difficile-associated diarrhea in adults","volume":"37","author":"Cruz","year":"2012","journal-title":"P T"},{"key":"10.1053\/j.gastro.2025.04.028_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","article-title":"PDGF in organ fibrosis","volume":"62","author":"Klinkhammer","year":"2018","journal-title":"Mol Aspects Med"},{"key":"10.1053\/j.gastro.2025.04.028_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209786","article-title":"Blockade of platelet-derived growth factor receptor-beta, not receptor-alpha ameliorates bleomycin-induced pulmonary fibrosis in mice","volume":"13","author":"Kishi","year":"2018","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2025.04.028_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911021","article-title":"Dysregulated mesenchymal PDGFR-beta drives kidney fibrosis","volume":"12","author":"Buhl","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1053\/j.gastro.2025.04.028_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0976-500X.149141","article-title":"Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: a single-center surveillance study","volume":"6","author":"Francis","year":"2015","journal-title":"J Pharmacol Pharmacother"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2025.04.028_bib40","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1093\/cid\/cis337","article-title":"Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection","volume":"55","author":"Sears","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16753-z","article-title":"CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2025.04.028_bib42","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.7150\/thno.47717","article-title":"Glycogen synthase kinase-3beta: a promising candidate in the fight against fibrosis","volume":"10","author":"Zheng","year":"2020","journal-title":"Theranostics"},{"key":"10.1053\/j.gastro.2025.04.028_bib43","first-page":"931","article-title":"Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice","volume":"8","author":"Singh","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1053\/j.gastro.2025.04.028_bib44","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.2174\/1570159X20666220411081728","article-title":"What is the role of lithium in epilepsy?","volume":"20","author":"Bojja","year":"2022","journal-title":"Curr Neuropharmacol"},{"key":"10.1053\/j.gastro.2025.04.028_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030559","article-title":"Isoform-specific role of GSK-3 in high fat diet induced obesity and glucose intolerance","volume":"11","author":"Gupte","year":"2022","journal-title":"Cells"},{"key":"10.1053\/j.gastro.2025.04.028_bib46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2337\/db16-0881","article-title":"PDGFRbeta regulates adipose tissue expansion and glucose metabolism via vascular remodeling in diet-induced obesity","volume":"66","author":"Onogi","year":"2017","journal-title":"Diabetes"},{"key":"10.1053\/j.gastro.2025.04.028_bib47","article-title":"Fidaxomicin and OP-1118 inhibit Clostridium difficile toxin A- and B-mediated inflammatory responses via inhibition of NF-kappaB activity","volume":"62","author":"Koon","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2025.04.028_bib48","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"10.1053\/j.gastro.2025.04.028_bib49","first-page":"19","article-title":"Production of TNF-alpha by peripheral blood mononuclear cells through activation of nuclear factor kappa B by specific allergen stimulation in patients with atopic asthma","volume":"24","author":"Mitsuta","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"10.1053\/j.gastro.2025.04.028_bib50","article-title":"NF-kappa B activation correlates with disease phenotype in Crohn's disease","volume":"12","author":"Han","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2025.04.028_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc4822","article-title":"Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia","volume":"13","author":"Zeisig","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.gastro.2025.04.028_bib52","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/ibd\/izaf021","article-title":"Novel transcriptomic signatures in fibrostenotic Crohn's disease: dysregulated pathways, promising biomarkers, and putative therapeutic targets","volume":"31","author":"Acharjee","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bib53","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2023.07.014","article-title":"Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions","volume":"165","author":"Mukherjee","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.04.028_bibe1","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2353\/ajpath.2010.100314","article-title":"Substance P modulates colitis-associated fibrosis","volume":"177","author":"Koon","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2025.04.028_bibe2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.omto.2019.01.004","article-title":"Cathelicidin suppresses colon cancer metastasis via a P2RX7-dependent mechanism","volume":"12","author":"Wang","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"10.1053\/j.gastro.2025.04.028_bibe3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcmgh.2014.08.001","article-title":"Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis","volume":"1","author":"Yoo","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.04.028_bibe4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16753-z","article-title":"CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2025.04.028_bibe5","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1023\/A:1012334727509","article-title":"Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system","volume":"46","author":"Kruschewski","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.04.028_bibe6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ibd.21812","article-title":"Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a \"Top-Down\u201d approach to intestinal fibrosis in mice","volume":"18","author":"Johnson","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bibe7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jcmgh.2022.06.011","article-title":"Elafin reverses intestinal fibrosis by inhibiting cathepsin S-mediated protease-activated receptor 2","volume":"14","author":"Xie","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.04.028_bibe8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/infdis\/jiad008","article-title":"Genistein inhibits Clostridioides difficile infection via estrogen receptors and lysine-deficient protein kinase 1","volume":"227","author":"Xie","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1053\/j.gastro.2025.04.028_bibe9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101474","article-title":"Citrulline inhibits Clostridioides difficile infection with anti-inflammatory effects","volume":"19","author":"Xie","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.04.028_bibe10","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1053\/j.gastro.2011.06.079","article-title":"Cathelicidin signaling via the Toll-like receptor protects against colitis in mice","volume":"141","author":"Koon","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525007656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525007656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:25:01Z","timestamp":1778473501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525007656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0016508525007656"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.04.028","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}